Melvin Hank Seid MD FACOG

Clinical Trials

• Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women Start of enrollment: 2004 Apr 01

  Completed

  Phase 3

• Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS Start of enrollment: 2005 Jul 01

  Completed

  Phase 3

• Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes Start of enrollment: 2004 Dec 01

  Completed

  Phase 4

• Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception Start of enrollment: 2003 Feb 01

  Completed

  Phase 3

• Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis Start of enrollment: 2005 May 01

  Completed

  Phase 2

• Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients Start of enrollment: 2006 May 01

  Completed

  Phase 3

• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension Start of enrollment: 2006 Jul 01

  Completed

  Phase 3

• Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS) Start of enrollment: 2006 Jul 01

  Completed

  Phase 3

• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder Start of enrollment: 2006 Jun 01

  Completed

  Phase 4

• Study of Safety and Efficacy of an Oral Contraceptive Start of enrollment: 2006 Nov 01

  Completed

  Phase 3

• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding Start of enrollment: 2005 May 01

  Completed

  Phase 3

• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia Start of enrollment: 2005 Feb 01

  Completed

  Phase 3

• The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor Start of enrollment: 2007 Oct 12

  Completed

  Phase 2

• Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension Start of enrollment: 2007 Jan 01

  Completed

  Phase 2

• Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) Start of enrollment: 2006 Feb 01

  Completed

  Phase 2

• Low-dose Hormone Therapy for Relief of Vasomotor Symptoms Start of enrollment: 2007 Mar 01

  Completed

  Phase 3

• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women Start of enrollment: 2007 Apr 01

  Completed

  Phase 3

• Efficacy and Safety Study for an Oral Contraceptive Containing Folate Start of enrollment: 2007 Apr 01

  Completed

  Phase 3

• Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study Start of enrollment: 2007 Aug 01

  Completed

  Phase 3

• Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients Start of enrollment: 2007 Oct 01

  Completed

  Phase 3

• Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ Start of enrollment: 2007 Oct 01

  Completed

  Phase 3

• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women Start of enrollment: 2008 Jan 01

  Completed

  Phase 3

• Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension Start of enrollment: 2008 May 01

  Completed

  Phase 3

• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia Start of enrollment: 2008 Jul 01

  Completed

  Phase 3

• Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia Start of enrollment: 2008 Jun 01

  Completed

  Phase 3

• Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity Start of enrollment: 2008 Jul 01

  Completed

  Phase 3

• Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia Start of enrollment: 2005 Jun 01

  Completed

  Phase 3

• A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis Start of enrollment: 2008 Dec 18

  Terminated

  Phase 2

• Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis Start of enrollment: 2009 Jan 01

  Completed

  Phase 3

• Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles Start of enrollment: 2009 May 01

  Completed

  Phase 3

• Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome Start of enrollment: 2009 Jul 01

  Completed

  Phase 2

• US Cycle Control and Blood Pressure Study Start of enrollment: 2009 Jun 01

  Completed

  Phase 3

• A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females Start of enrollment: 2009 Jun 01

  Completed

  Phase 2

• Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Start of enrollment: 2009 Sep 01

  Completed

  Phase 3

• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia Start of enrollment: 2010 Jun 19

  Completed

  Phase 3

• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia Start of enrollment: 2010 Jul 27

  Completed

  Phase 3

• Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System Start of enrollment: 2010 Aug 01

  Completed

  Phase 3

• Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm Start of enrollment: 2010 Oct 01

  Completed

  Phase 3

• Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Start of enrollment: 2010 Sep 01

  Completed

  Phase 2

• Essure Transvaginal Ultrasound (TVU) Study Start of enrollment: 2011 May 17

  Completed

  Phase 4

• Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder Start of enrollment: 2011 Jun 01

  Completed

  Phase 2

• The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005) Start of enrollment: 2012 Apr 13

  Terminated

  Phase 2

• Effect of KYG0395 on Primary Dysmenorrhea Start of enrollment: 2012 May 01

  Completed

  Phase 2

• A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Start of enrollment: 2013 Aug 01

  Completed

  Phase 2

• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms Start of enrollment: 2013 Aug 05

  Completed

  Phase 3

• IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose Start of enrollment: 2014 May 01

  Completed

  Phase 3

• A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas Start of enrollment: 2014 Jan 29

  Completed

  Phase 3

• Join now to see all